LakeShore Biopharma Co., Ltd. (LSBWF) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
LSBWF Profit Margin, ROE & Profitability Analysis
LSBWF vs Healthcare Sector: How LakeShore Biopharma Co., Ltd. Compares
How LakeShore Biopharma Co., Ltd. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is LakeShore Biopharma Co., Ltd. Stock Overvalued? LSBWF Valuation Analysis 2026
Based on fundamental analysis, LakeShore Biopharma Co., Ltd. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
LakeShore Biopharma Co., Ltd. Balance Sheet: LSBWF Debt, Cash & Liquidity
LSBWF Revenue Growth, EPS Growth & YoY Performance
LSBWF SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for LakeShore Biopharma Co., Ltd. (CIK: 0001946399)
📋 Recent SEC Filings
❓ Frequently Asked Questions about LSBWF
What is the AI rating for LSBWF?
LakeShore Biopharma Co., Ltd. (LSBWF) has an AI grade of N/A with 0% confidence, based on fundamental analysis of SEC EDGAR filings.
What are LSBWF's key strengths?
Claude: Analysis in progress.
What are the risks of investing in LSBWF?
Claude: Analysis in progress.
What is LSBWF's revenue and growth?
LakeShore Biopharma Co., Ltd. reported revenue of N/A.
Does LSBWF pay dividends?
LakeShore Biopharma Co., Ltd. does not currently pay dividends.
Where can I find LSBWF SEC filings?
Official SEC filings for LakeShore Biopharma Co., Ltd. (CIK: 0001946399) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is LSBWF's EPS?
LakeShore Biopharma Co., Ltd. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is LSBWF's fundamental grade?
Based on our AI fundamental analysis in July 2026, LakeShore Biopharma Co., Ltd. has a N/A grade with 0% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is LSBWF stock overvalued or undervalued?
Valuation metrics for LSBWF: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is LSBWF's AI grade for 2026?
Our dual AI analysis gives LakeShore Biopharma Co., Ltd. a combined N/A grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is LSBWF's free cash flow?
LakeShore Biopharma Co., Ltd.'s operating cash flow is N/A, with capital expenditures of N/A.
How does LSBWF compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 2).